Steve Ryder
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
- Toxicology top 1%
- Forensic Toxicology and Drug Analysis
Papers in
-
- Prostate Cancer Treatment and Research 3
- Surgery 4
- Co-authors
- Jos Kleijnen (19 shared papers)Penny Whiting (4 shared papers)Kate Misso (3 shared papers)Nigel Armstrong (22 shared papers)Steven Duffy (10 shared papers)Robert Wolff (6 shared papers)Sohan Deshpande (4 shared papers)Adrían V. Hernández (1 shared paper)
- Journals
- PharmacoEconomics (9 papers)Health Technology Assessment (7 papers)JAMA (1 paper)Current Medical Research and Opinion (1 paper)Clinical Epidemiology (1 paper)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Steve Ryder
26 papers receiving 2.7k citations
Steve Ryder's Hit Papers
Peers
Comparison fields: 5 of 139
- Pharmacology 1.3k
- Toxicology 159
- Critical Care and Intensive Care Medicine 192
- Hepatology 144
- Biochemistry 94
Countries citing papers authored by Steve Ryder
This map shows the geographic impact of Steve Ryder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Ryder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Ryder more than expected).
Fields of papers citing papers by Steve Ryder
This network shows the impact of papers produced by Steve Ryder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Ryder. The network helps show where Steve Ryder may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Ryder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cannabinoids for Medical Use Hit paper breakdown → | 2015 | 1492 |
| 2 | The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review Hit paper breakdown → | 2017 | 351 |
| 3 | 2015 | 217 | |
| 4 | 2019 | 163 | |
| 5 | 2007 | 137 | |
| 6 | 2015 | 86 | |
| 7 | 2014 | 80 | |
| 8 | 2015 | 63 | |
| 9 | 2016 | 52 | |
| 10 | 2021 | 49 | |
| 11 | 2013 | 39 | |
| 12 | 2019 | 17 | |
| 13 | 2019 | 16 | |
| 14 | 2016 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2005 | 11 | |
| 17 | 2020 | 8 | |
| 18 | 2022 | 6 | |
| 19 | 2020 | 5 | |
| 20 | 2018 | 5 |
About Steve Ryder
Steve Ryder is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Cardiology and Cardiovascular Medicine, Oncology and Epidemiology, having authored 28 papers that have together received 2.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Diabetes Management and Research (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Cannabis and Cannabinoid Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Cerebral Palsy and Movement Disorders (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Pharmacology (1.3k citations), Toxicology (159 citations), Critical Care and Intensive Care Medicine (192 citations), Hepatology (144 citations) and Biochemistry (94 citations). Steve Ryder has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Jos Kleijnen, Penny Whiting, Kate Misso, Nigel Armstrong, Steven Duffy, Robert Wolff, Sohan Deshpande, Adrían V. Hernández, Shona Lang and J. Christiaan Keurentjes. Their work appears in journals such as PharmacoEconomics, Health Technology Assessment, JAMA, Current Medical Research and Opinion and Clinical Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.